Introduction {#sec1-1}
============

Calcium (Ca) is one of the most important extracellular cation.\[[@ref1]\] Approximately, 99% of the body\'s Ca is stored in the bones and teeth.\[[@ref2]\] Apart from supporting the skeletal integrity, Ca plays an important role in blood clots, muscular contractility and nervous excitability.\[[@ref3]\] Although serum Ca levels can be maintained in the normal range by bone resorption, dietary intake is the only source by which the body can replenish stores of Ca in bone. Ca is absorbed almost exclusively within the duodenum, jejunum and ileum. Each of these intestinal segments has a high absorptive capacity for Ca, with their relative Ca absorption being dependent on the length of each respective intestinal segment and the transit time of the food bolus. The calcium intake is critical during the 1^st^ year of life for the anatomical structure.\[[@ref4]\] Prospective studies demonstrated that the biggest increase of the bone mass occurs principally during the age of puberty.\[[@ref5]\] An inadequate calcium intake during the growth period may cause a failure to reach the increase in bone mass. This situation produces different bone and illnesses such as osteopenia, osteoporosis, decreased skeletal integrity, increasing the fracture risk in later life.\[[@ref6]\] Some of the researchers have reported that the increase in calcium intake attenuates the bone mass loss during the age of menopause.\[[@ref7][@ref8][@ref9]\] It appears that all the calcium in food or other source is available for absorption, but the absolute amount is determined by physiological factors such as efficiency of absorption, calcium need, vitamin D, age and hormonal status, etc.\[[@ref10][@ref11]\]

Calcium sandoz is a popular brand of calcium supplement, used widely throughout the world; mainly by children and women. Calcium sandoz contains calcium carbonate as the main ingredient.\[[@ref12]\] However, calcium sandoz-250 contains *Khatika Churna*, as it is an ayurvedic preparation and it is claimed to have 250 mg calcium equivalent in each chewable tablet.\[[@ref13][@ref14]\] Bioavailability of calcium from calcium sandoz-250 was studied in animal model as a preclinical trial. There have been no studies in humans about the bioavailability of calcium from calcium sandoz-250. As calcium sandoz-250 is an Ayurvedic formulation, the absorption might shows variations from the data of the allopathic formulation of calcium supplements or food.\[[@ref15][@ref16][@ref17]\]

Materials and Methods {#sec1-2}
=====================

Animals {#sec2-1}
-------

Adult male wistar albino rats (*n* = 12) weighing 120-150 g were procured from central animal facility and housed in cages under standard laboratory conditions (10 h dark/14 h light, temperature 20-25°C, relative humidity 65%) for 7 days.

Reagents and chemicals {#sec2-2}
----------------------

Ultra-pure water, metal standard solutions of calcium (sigma Aldrich) were prepared by appropriate dilutions of 1000 mg/L stock solutions.

Instrumentation {#sec2-3}
---------------

Shimadzu model AA 6300 flame atomic absorption spectrometer (AAS) (Tokyo--Japan) equipped with a deuterium background corrector and a hydride vapor generator for analysis of arsenic. Hollow cathode lamps of specific metals were used as a radiation source.

Study design {#sec2-4}
------------

The study was randomized single dose study, included two equal groups of animals (*n* = 6 in each). The protocol was duly approved by the Institutional animal ethics committee (No. JSSCP/IAEC/M.PHARM/PHARM.ANALYSIS/05/2009-2010).

Drug assignment {#sec2-5}
---------------

Two equal groups were made from all albino rats. First group received calcium sandoz-250 (dose was calculated according to the body weight of the animal) and the second group kept as control.

Single dose of calcium sandoz was given to each of the six rats after an overnight fasting. Blood sample was collected from the tail vein of rats after 0.0, 0.15, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 8.0, 12.0, 24.0 and 36.0 hrs of drug administration. The amount of calcium sandoz was measured by a suitable flame AAS method.

Preparation of standard calcium solution {#sec2-6}
----------------------------------------

Standard calcium solutions were prepared from 1000 mg/L stock solution. A serial dilution containing 0.5, 1.0, 1.5, 2.0 and 2.5 ppm of calcium were prepared and used as working standards.

These solutions were then subjected to analysis by flame AAS under the following instrumental conditions:
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The absorbances of the standard solutions were recorded and the calibration curve was plotted by taking concentration in *X*-axis and absorbance in *Y*-axis.

Estimation of calcium in plasma samples {#sec2-7}
---------------------------------------

### Optimization of the extraction procedure {#sec3-1}

For the estimation of calcium in plasma, animal plasma was spiked with standard calcium solution. To precipitate the plasma protein as they may coagulate on heating, the following methods were tried:

Precipitation of plasma proteins with perchloric acid (10%)Precipitation of plasma proteins with trichloroacetic acid (10% and 20%)Precipitation of plasma proteins with nitric acidDilution of the plasma samples 50 fold with deionized water.

### Methods {#sec3-2}

A total volume of 0.2 ml plasma was taken, to this appropriate amount of standard calcium solution (2.0 ppm) and 0.2 ml of precipitating agents (perchloric acid, trichloroacetic acid and nitric acid) were added. The volume was made to 1 ml with deionized water. The resulting solutions were centrifuged at 4000 rpm for 5 min and supernatant was taken and diluted to 10 ml with deionized water.

However in all cases recovery were found to be less than 50%, so finally direct estimation was done by diluting the plasma by 50 fold using deionized water. The resulting samples on analysis gave good recovery (above 95%).

Calibration curve was plotted for the concentration range of 0.5 ppm to 2.5 ppm in plasma and the method was validated for following parameters

LinearityRangePrecisionAccuracy.

The samples obtained from the animal study were analyzed by the same method.

Results and Discussion {#sec1-3}
======================

Linearity curve was plotted for the solutions of calcium solutions ranging from 0.5 μg/ml to 2.5 μg/ml \[[Table 1](#T1){ref-type="table"}\], giving *R*^2^ value 0.9975 and slope 0.0163 \[[Figure 1](#F1){ref-type="fig"}\].

###### 

Linearity range of calcium standard solution by AAS
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![Linearity plot of calcium standard solution by atomic absorption spectroscopic](AYU-35-438-g003){#F1}

Extraction method was optimized for extraction of calcium from the plasma. Recovery with protein precipitation was less than 50% for almost all precipitating agent, while direct determination of calcium with 50 fold dilution gave 98.5% recovery \[[Table 2](#T2){ref-type="table"}\]. Recovery was studied for all the concentration of the calibration curve giving the result between 94.28% and 107.14% \[[Table 3](#T3){ref-type="table"}\].

###### 

Optimization of method
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###### 

Linearity and recovery study
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Calibration curve was plotted for the plasma samples spiked with the known amount of calcium, with *R*^2^ value 0.995, slope 0.014 and intercept 0.001 \[[Table 4](#T4){ref-type="table"}, [Figure 2](#F2){ref-type="fig"}\].

###### 

Calibration curve of calcium in plasma by AAS
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![Calibration curve of calcium in atomic absorption spectroscopic](AYU-35-438-g007){#F2}

Plasma samples collected from the animals at different intervals were analyzed for the calcium content after blank was introduced, detectable amount measured after 15 min of administration. Pharmacokinetic parameters such as peak plasma concentration (*C*~max~), Time to peak concentration (*T*~max~), Area under the plasma concentration-time curve (AUC~0-t~ and AUC~0-∞~) were calculated for calcium on administration of calcium sandoz-250 \[[Table 5](#T5){ref-type="table"}\].

###### 

Mean plasma concentration of calcium from animal (administered calcium sandoz-250)
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[Figure 3](#F3){ref-type="fig"} shows bioavailability curve of the calcium after oral administration of calcium sandoz-250. A summary of different pharmacokinetic parameters was depicted in [Table 6](#T6){ref-type="table"}.
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###### 

Pharmacokinetic parameters
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Pharmacokinetics data of calcium sandoz-250 obtained from bioavailability study {#sec2-8}
-------------------------------------------------------------------------------

Pharmacokinetic parameters such as *C*~max~, *T*~max~, AUC~0-t~ and AUC~0-∞~ were calculated for calcium on administration of calcium sandoz-250Measurable calcium-blood levels were noticed in all subjects up to 3.0 h after administration of calcium sandoz-250The *C*~max~, i.e. *C*~max~ after administration of calcium sandoz-250 was 0.793 μg/ml at 90 min (*T*~max~)AUC~0-t~ and AUC~0-∞~ were found to be 79.28571 and 80.82454 respectively*K*~eli~ and half-life for the calcium sandoz-250 (Ayurvedic formulation) were found to be 0.030172 and 22.97 min respectively.

Conclusion {#sec1-4}
==========

On the basis of the results obtained from the study, conclusion can be drawn that calcium Sandoz-250, consisting of *Khatika Churna*, increases the blood calcium level in albino rats. Hence, further investigation should be carried out to evaluate the effect of calcium sandoz-250 on human blood calcium level.
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